Heron Therapeutics, Inc.
HRTX· Nasdaq
HRTXHeron Therapeutics, Inc.
Filed Nov 6, 2014 · 10-Q · 37 days after period end · 0001193125-14-400994
| Metric | Q3 2014 | Q3 2013 | Q3 2012 | Q3 2011 |
|---|---|---|---|---|
| Net Income | -$19.19M | -$12.87M | -$6.12M | -$4.20M |
| EPS Diluted | -$0.66 | -$0.84 | -$0.45 | -$0.02 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Heron Therapeutics, Inc. · CIK 818033 · Engraved from SEC EDGAR
ended Sep 30, 2014 · filed Nov 6, 2014 · 37 d after period end
